Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans.

Clinical research has always been the backbone of medical progress, providing the data and insights needed to develop new ...

Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study March 23, 2026 4:30 ...

No Observed Events of Any Grade of Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome, or Graft-vs-Host Disease SAN DIEGO, Dec. 06, 2020 (GLOBE NEWSWIRE) -- Fate ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its external research ...

Credit: Getty Images. Worldwide, 2% to 12% of people diagnosed with type 2 diabetes have latent autoimmune diabetes in adulthood (LADA). A 41-year-old Hispanic woman presents to her worksite clinic ...

Wild blueberries—the iconic Maine crop dotting hillsides, decorating sweatshirts and adding personality to local menus—is ...

The numbers related to opioid dependence and addiction are staggering: More than 10 million people misuse opioids and almost 50,000 people die from opioid overdose every year -- a 519% increase since ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

Sepsis, a common complication following burns, trauma, and major surgery, remains the leading cause of death among critically ill patients. Globally, there are about 48.9 million sepsis patients and ...

A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations ...